Editorial: Should we manage patients with non-st segment elevation myocardial infarction with renal failure with an invasive strategy?

Circulation

Volumn 120, Issue 10, 2009, Pages 828-830

  Cannon, Christopher P ^a,b,c  

^a Thrombolysis in Myocardial Infarction Study Group   (Canada)

^b Women's Hospital   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Catheterization; Editorials; Kidney; Myocardial infarction; Revascularization; Stents.

Indexed keywords

CORONARY ARTERY DISEASE; DIALYSIS; EDITORIAL; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; KIDNEY FAILURE; MORTALITY; PRIORITY JOURNAL; REVASCULARIZATION; ST SEGMENT ELEVATION; ELECTROCARDIOGRAPHY; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; NOTE; PATHOPHYSIOLOGY; STATISTICS;

ELECTROCARDIOGRAPHY; HUMANS; KIDNEY FAILURE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; SEVERITY OF ILLNESS INDEX;

EID: 70349764805     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.888602     Document Type: Editorial

References (21)

1. Szummer K, Lundman P, Jacobson SH, Schön S, Lindbäck J, Stellestrand U, Wallentin L, Jernberg T, for SWEDEHEART. Influence of renal function on the effects of early revascularization in non-ST elevation myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation. 2009;120:851-858.
2. 2. Fox KA, Antman EM, Montalescot G, Agewall S, SomaRaju B, Verheugt FW, Lopez-Sendon J, Hod H, Murphy SA, Braunwald E. The impact of renal dysfunction on outcomes in the ExTRACT-TTMI 25 trial. J Am Coll Cardiol. 2007;49:2249-2255. (Pubitemid 46863477)
3. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE II, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007; 50:el-el57.
4. 4. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, FernandezAviles F, Fox KA, Hasdai D, Ohman EM, Wallentin L, Wijns W. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598-1660. (Pubitemid 350305871)
5. 5. Roe MT, Peterson ED, Newby LK, Chen AY, Pollack CV Jr, Brindis RG, Harrington RA, Christenson RH, Smith SC Jr, Califf RM, Braunwald E, Gibier WB, Ohman EM. The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2006;151:1205-1213. (Pubitemid 44172870)
6. 6.RossouwJE,AndersonGL,PrenticeRL,LaCroixAZ,KooperbergC,StefanickML, JacksonRD,BeresfordSA,HowardBV,JohnsonKC,KotchenJM,OckeneJ. Risksandbenefitsofestrogenplusprogestininhealthypostmenopausalwomen: principalresultsfromtheWomen'sHealthInitiativerandomizedcontrolledtrial.JAMA. 2002;288:321-333.(Pubitemid34761611)
7. Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, Manson JE. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA. 2008;300:2012-2021.
8. 8.YusufS,DagenaisG,PogueJ,BoschJ,SleightP,fortheHeartOutcomesPrevention. EvaluationStudyInvestigators. VitaminEsupplementationandcardiovasculareventsinhigh-riskpatients.NEnglJMed. 2000;342:154-160.(Pubitemid30185776)
9. Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, Low M, Greenson JK, Rennert G. Statins and the risk of colorectal cancer. N Engl J Med. 2005;352:2184-2192.
10. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366: 1267-1278.
11. Dale KM, Coleman CI, Henyan NN, Kluger J, White CM. Statins and cancer risk: a meta-analysis. JAMA. 2006;295:74-80.
12. 12. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356:1009-1019. (Pubitemid 46376801)
13. 13. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran. R, Leon MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998-1008. (Pubitemid 46376800)
14. 14. James SK, Stenestrand U, Lindback J, Carlsson J, Schersten F, Nilsson T, Wallentin L, Lagerqvist B. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N.Engl J.Med. 2009;360:1933-1945. (Pubitemid 46376801)
15. Steg PG, Fox KA, Eagle KA, Furman M, Van de Werf F, Montalescot G, Goodman SG, Avezum. A, Huang W, Gore JM. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction, in the Global Registry of Acute Coronary Events. Eur Heart J. 2009;30:321-329.
16. Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Meckel M, Ochala A, Kellock A, Parise H, Mehran. R. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009;360:1946-1959.
17. 17. Januzzi JL, Cannon CP, DiBattiste PM, Murphy S, Weintraub W, Braunwald E. Effects of renal insufficiency on early invasive management in. patients with acute coronary syndromes (the TACTICS-TIMI 18 Trial). Am J Cardiol. 2002;90:1246-1249. (Pubitemid 35350859)
18. 18. Johnston N, Jernberg T, Lagerqvist B, Wallentin L. Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease. Am Heart J. 2006;152:1052-1058. (Pubitemid 44856711)
19. Charytan DM, Wallentin L, Lagerqvist B, Spacek R, De Winter RJ, Stern NM, Braunwald E, Cannon CP, Choudhry NK. Early angiography in patients with chronic kidney disease: a collaborative systematic review. Clin J Am Soc Nephrol. 2009;4:1032-1043.
20. Hirsch A, Windhausen F, Tijssen JG, Oude Ophuis AJ, van der Giessen WJ, van der Zee PM, Cornel JH, Verbeugt FW, de Winter RJ. Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias. Eur Heart J. 2009;30:645-654.
21. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Gronhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Suleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wuthrich RP, Gottlow M, Johnsson E, Zannad F. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360:1395-1407.